hoptis
Bluelight Crew
- Joined
- May 1, 2002
- Messages
- 11,083
Bluelight is proud to support the Psychedelic Science in the 21st Century conference, in San Jose, CA, April 15-18, 2010. Register by 31st December 2009 for reduced rates.
The Multidisciplinary Association for Psychedelic Studies (MAPS) presents Psychedelic Science in the 21st Century conference, in San Jose, CA, April 15-18, 2010.
www.maps.org/conference
Psychedelic Science will showcase contemporary psychedelic research and psychedelic psychotherapy topics at the largest conference in the U.S. in 17 years dedicated solely to psychedelics. Three full days of programming will be offered with concurrent tracks exploring clinical applications, issues relevant to healthcare and mental health professionals, and social, cultural and psychological issues surrounding the therapeutic and spiritual uses of psychedelics.
There will also be pre- and post-conference workshops with Stanislav Grof, M.D., Rick Doblin, Ph.D., Michael Mithoefer, M.D. Annie Mithoefer, and others to be determined.
The conference is open to the general public. Continuing Medical Education (CME) credits are available for medical doctors and ancillary medical professionals.
International experts in the CME track will present the state of the art of psychedelic science and psychedelic psychotherapy studies, including:
Speakers in the CME track include:
The cultural and psychotherapy (non-CME) track will have presentations on issues surrounding the therapeutic and spiritual uses of psychedelics. The call for proposals to present in this section is available at: www.maps.org/conference
Speakers in the cultural and psychotherapy tracks include:
There will be a special benefit dinner on the evening of Saturday, April 17, 2010, with guests of honor Ann and Alexander "Sasha" Shulgin, whose lifetime of achievements are inspiring. As a pharmacologist and chemist Sasha discovered numerous new psychoactive chemicals and authored the legendary books TIHKAL and PIHKAL, and hundreds of other scientific papers. Ann and Sasha are legendary for bringing rational and scientific perspectives to self-experimentation and psychoactive ingestion.
This activity has been planned and implemented in accordance with the Institute for Medical Quality and the California Medical Association’s CME Accreditation Standards (IMQ/CMA) through the Joint-Sponsorship of CME Consultants and the Multidisciplinary Association for Psychedelic Studies (MAPS). CME Consultants is accredited by IMQ/CMA to provide continuing medical education for physicians. CME Consultants takes responsibility for the content, quality and scientific integrity of this CME activity.
CME Consultants designates this educational activity for a maximum of 15.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
The Multidisciplinary Association for Psychedelic Studies (MAPS) presents Psychedelic Science in the 21st Century conference, in San Jose, CA, April 15-18, 2010.
www.maps.org/conference
Psychedelic Science will showcase contemporary psychedelic research and psychedelic psychotherapy topics at the largest conference in the U.S. in 17 years dedicated solely to psychedelics. Three full days of programming will be offered with concurrent tracks exploring clinical applications, issues relevant to healthcare and mental health professionals, and social, cultural and psychological issues surrounding the therapeutic and spiritual uses of psychedelics.
There will also be pre- and post-conference workshops with Stanislav Grof, M.D., Rick Doblin, Ph.D., Michael Mithoefer, M.D. Annie Mithoefer, and others to be determined.
The conference is open to the general public. Continuing Medical Education (CME) credits are available for medical doctors and ancillary medical professionals.
International experts in the CME track will present the state of the art of psychedelic science and psychedelic psychotherapy studies, including:
- Biological and neurological effects of psychedelic substances
- MDMA-(ecstasy) assisted psychotherapy for the treatment of posttraumatic stress disorder (PTSD)
- Psychedelic psychotherapy for treating anxiety and depression associated with life-threatening illnesses
- Mystical-type experiences catalyzed by psychedelics and their therapeutic implications
- Psychedelics’ role in the treatment of drug addiction
- Psilocybin research with obsessive-compulsive disorder
- Standards for conducting psychedelic psychotherapy research
Speakers in the CME track include:
- Matt Baggott, Ph.D. Candidate, (UC Berkeley, LSD, MDMA, MDA, Salvia Divinorum researcher)
- Jose Carlos Bouso, Psychologist, Ph.D. Candidate (Spain, MDMA/PTSD researcher)
- Alicia Danforth, Ph.D. Candidate (ITP, UCLA psilocybin researcher)
- Peter Gasser, M.D. (Switzerland, LSD/end-of-life anxiety researcher)
- Roland Griffiths, Ph.D. (JHU, psilocybin/mystical experiences researcher)
- Charles Grob, M.D. (UCLA, psilocybin/cancer anxiety researcher)
- Stanislav Grof, M.D. (Co-founder of transpersonal psychology, leading theorist in psychedelic psychotherapy, founder of holotropic breathwork)
- John Halpern, M.D. by video link (Harvard, neurocognitive consequences of ecstasy)
- Julie Holland, M.D. (NYU School of Medicine, psychiatric emergency services)
- Sergio Marchevsky, M.D. (Israel, MDMA/PTSD researcher)
- John Mendelson, M.D. (CPMC Research Institute, LSD, MDMA, MDA, Salvia Divinorum researcher)
- Michael Mithoefer, M.D. (U.S., MDMA/PTSD researcher)
- Francisco Moreno, M.D. (Psilocybin/OCD researcher)
- David Nichols, Ph.D. (Heffter Research Institute, Purdue University)
- Peter Oehen, M.D. (Switzerland, MDMA/PTSD researcher)
- Ingrid Pacey, M.D. (Canada, MDMA/PTSD researcher)
- Torsten Passie, M.D., Ph.D. (Germany, psilocybin research)
- Jordi Riba, M.D. (Spain, ayahuasca researcher)
- William Richards, Ph.D. (JHU, psilocybin/cancer anxiety researcher)
- Stephen Ross, M.D. (NYU, psilocybin/cancer anxiety researcher)
- Ben Sessa, M.D. (UK, psilocybin researcher)
- Franz Vollenweider ,M.D. (Switzerland, psychedelic neuroscience researcher)
- Andrew Weil, MD, - by live video. (Integrative medicine, introducing new approaches to medicine without backlash)
- Michele Weitz, B.A. (U.S., Clinical Research Expert)
The cultural and psychotherapy (non-CME) track will have presentations on issues surrounding the therapeutic and spiritual uses of psychedelics. The call for proposals to present in this section is available at: www.maps.org/conference
Speakers in the cultural and psychotherapy tracks include:
- Amanda Feilding, (Director of The Beckley Foundation)
- Frank Echenhofer, Ph.D. (California Institute of Integral Studies)
- Earth and Fire Erowid (founders of erowid.org)
- Carolyn Garcia, aka Mountain Girl
- Neal Goldsmith, Ph.D. (Author, Psychotherapist)
- Alex and Allyson Grey (Chapel Of Sacred Mirrors)
- James Fadiman, Ph.D. (Institute of Transpersonal Psychology)
- Ralph Metzner, Ph.D. (Green Earth Foundation)
- Tom Pinkson, Ph.D. (Psychotherapist)
- Thomas Roberts, Ph.D. (Northern Illinois University)
- Many others yet to be announced
There will be a special benefit dinner on the evening of Saturday, April 17, 2010, with guests of honor Ann and Alexander "Sasha" Shulgin, whose lifetime of achievements are inspiring. As a pharmacologist and chemist Sasha discovered numerous new psychoactive chemicals and authored the legendary books TIHKAL and PIHKAL, and hundreds of other scientific papers. Ann and Sasha are legendary for bringing rational and scientific perspectives to self-experimentation and psychoactive ingestion.
This activity has been planned and implemented in accordance with the Institute for Medical Quality and the California Medical Association’s CME Accreditation Standards (IMQ/CMA) through the Joint-Sponsorship of CME Consultants and the Multidisciplinary Association for Psychedelic Studies (MAPS). CME Consultants is accredited by IMQ/CMA to provide continuing medical education for physicians. CME Consultants takes responsibility for the content, quality and scientific integrity of this CME activity.
CME Consultants designates this educational activity for a maximum of 15.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.